ACASTI PHARMA

Codice
ACST
Risorse esterne
Opinione della community
Prezzo Variazione Volume
1.3201 +0.01 €
(+0.76%)
18730
P/E Obiettivo ad 1anno
0 8.21 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 125
Sell : 46

LucaMazzu91 Trader M Re di cuori matthi berchtold Salvatore Gagliotta Alessandro Yu Filippo Galmarini Genny cash Simone Bonzanini Luigi Caputo

Commenti


Notizie

Bounding Shares, What's Next for Acasti Pharma Inc. (NASDAQ ... - Morgan Research

Let's take a quick look at how the price of Acasti Pharma Inc. (NASDAQ:ACST) is currently trading in comparison to some of its simple moving averages. At current levels, shares have been seen trading 1.06% away from the 20-day moving average. The stock ...altro » Leggi

Critical Ownership Status in Focus: Yintech Investment Holdings ... - Wallstreet Investorplace

The two firms have made a persuasive message for passive investors over ownership structure. Yintech Investment Holdings Limited (NASDAQ:YIN) knocked up of 0.10% and Acasti Pharma Inc. (NASDAQ:ACST) change was -0.55% in latest trading session.altro » Leggi

Acasti Pharma, Inc. (NASDAQ:ACST) Experiences Heavier than ... - Finance Daily

44K shares changed hands on Wednesday. Overall, volume was up 164.13% over the stocks normal daily volume. Traders are more bullish recently as evidenced by the motion in short interest. The firm saw a fall in short interest of -94.08% between August ...altro » Leggi

Acasti Pharma (ACST) Earning Somewhat Positive Press Coverage ... - StockNewsTimes

Acasti Pharma (ACST) traded down 0.19% during trading on Friday, reaching $1.28. The company had a trading volume of 7,991 shares. The firm's market capitalization is $18.83 million. The stock has a 50 day moving average price of $1.30 and a 200 day ...altro » Leggi

Credit Suisse Cuts Time Warner (TWX) To “Neutral” from ... - Herald KS

Acasti Pharma Class A (NASDAQ:ACST) had a decrease of 94.09% in short interest. ACST's SI was 1,100 shares in September as released by FINRA. Its down 94.09% from 18,600 shares previously. The SI to Acasti Pharma Class A's float is 0.02%. The stock ... Leggi

Gw Henssler & Associates LTD Cut By $440216 Its Cognizant ... - UtahHerald.com

Acasti Pharma Class A (NASDAQ:ACST) had a decrease of 94.09% in short interest. ACST's SI was 1,100 shares in September as released by FINRA. Its down 94.09% from 18,600 shares previously. The SI to Acasti Pharma Class A's float is 0.02%. The stock ...altro » Leggi

Should You Buy Thor Industries, Inc. (NYSE:THO) On Current ... - AppsforPCdaily

Trading volume for Thor Industries, Inc. was 741K in the last trading session. Huntington National Bank now owns 983 shares of the construction ... The SI to Acasti Pharma Class A's float is 1.35%. The stock declined 1.46% or $1.62 reaching $109.49 on ...altro » Leggi

Varied Analyst Comments On Atlantic Power Corporation (AT), Juno ... - AppsforPCdaily

The Company's products include Krill-Based Nutraceutical Products, including Neptune Krill Oil, OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti ...altro » Leggi

Acasti Pharma Announces the Election of Its Directors, Changes to ... - Marketwired (press release)

16, 2017) - Acasti Pharma Inc. (NASDAQ:ACST)(TSX VENTURE:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, announced ... Mr ...altro » Leggi

Summary of what has been trade about Acasti Pharma Inc. (ACST ... - Wall Street Morning

Acasti Pharma Inc. (ACST) stock exposed a turn of 1.57% in most recent week and accomplished -2.27% performance over the last one month. The company ...altro » Leggi